Study | Newcastle-Ottawa Quality Assessment scale | Device | Population Sample size | Outcome measures | Findings |
---|---|---|---|---|---|
Fragiotta et al. 2023 [28] | 6 | SS-OCTA | -T1DM with mild NPDR: 22 cases (22 eyes) | -OCTA: CC FD % -AO: CD, LDi, and HPi -Fu: 4 y | - The CC FD exhibited a consistent increase over time (PÂ < 0.01). - The LDi and HPi were primarily impacted by choriocapillaris perfusion in the parafovea (PÂ = 0.02). - There was progressive deterioration of cone metrics over time due to worsening CC perfusion deficit. |
Chen et al. 2023 [44] | 6 | SS-OCTA | -T2DM without DR or with mild NPDR (no DME): 903 cases | -CC FD% -≥2 steps DR progression or development of DME -Fu: 3 y | − 16.34% developed DR progression, and 6.54% developed DME. - A higher average CC FD% was correlated with DR progression (OR, 3.41 per SD increase, 95% CI: 2.65–4.39, P < 0.001) and DME development (OR, 1.37 per SD increase, 95% CI: 1.06–1.77, P = 0.016) (especially in the inferior field) after adjusting for confounders. |
Guo et al. 2023 [45] | 6 | SS-OCTA | -T2DM without DR or with mild NPDR (no DME): 946 cases (1879 eyes) | -Parapapillary (3-mm) CC FD% -≥2 steps DR progression or development of DME -Fu: 3 y | − 16.60% experienced DR progression and 6.12% developed DME. - The DR progression was related to an elevated CC FD% (1.62, 1.40–1.88; P < 0.001). - The DME occurrence was associated with a higher CC FD% (1.29, 1.03–1.61; P < 0.001). |
Wang et al. 2022 [40] | 4 | SS-OCTA | -T2DM: 1222 patients (1222 eyes) | -CC FD% -1-year incidence of RDR | - Each 1% increase in baseline CC FD% was associated with 1.69 times (RR 2.69; 95% CI 1.53 to 4.71; p = 0.001) higher risk for development of RDR after 1 year. |